Splicing variant of AIMP2 as an effective target against chemoresistant ovarian cancer.

Integration Core

Authors Jin Woo Choi, Jeong-Won Lee, Jun Ki Kim, Hye-Kyung Jeon, Jung-Joo Choi, Dae Gyu Kim, young-Gie Kim, Do-Hyun Nam, Hong Joong Kim, Seok Hyun Yun, Sunghoon Kim
Journal Journal of Molecular Cell Biology
Vol.(no.) 4(3)
Pages 164-173
Year 20120604
DOI http://dx.doi.org/10.1093/jmcb/mjs018
Attach 20120604_J_Mol_Cell_Biol_4(3)_164-173.pdf


Related Post

Innovation of Drug Discovery through Novel Target ...
views 487
Asia Pacific Biotechnology News Click to enlarge. In order to move the screen, click and move the cursor while holding  
The Target Factory: Biocon’s Report II 2010-...
views 951
"The Target Factory" Biocon's Report II 2010-2015를 발간하였습니다. 의약바이오컨버젼스연구단(Biocon)의 비전과 전략을 비롯하여 2010년부터 2015년까지(글로벌프론티어사업 1, 2단계)의 연구 성과를 담았습니다.  PDF ...

Leave a reply

Your email address will not be published. Required fields are marked *



We're not around right now. But you can send us an email and we'll get back to you, asap.


©2010-2018 Medicinal Bioconvergence Research Center. All rights reserved.

Log in with your credentials

Forgot your details?

Skip to toolbar